EN
HI
Summary
As of 3 Oct, 2026, Samrat Pharmachem stock price is ₹232. During the trading session, the stock has moved between an intraday low of ₹232.00 and an intraday high of ₹247.95. Over the last 52 weeks, Samrat Pharmachem has traded between ₹190.00 and ₹320.00.
The stock has recorded a trading volume of 4,575 shares,. Its Average Traded Price (ATP) is ₹246.09, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 80 @ ₹232.00.
Samrat Pharmachem has an upper circuit limit of ₹244.45 and a lower circuit limit of ₹221.25. The total value traded stands at ₹11.26 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Samrat Pharmachem also offers a dividend yield of 0%.
Samrat Pharmachem Share Price Chart
Samrat Pharmachem Share Key Metrics
Volume
4575.00
Market Cap
71.94 CR
LTQ@LTP
80@232.00
ATP
246.09
Var Margin
25 %
Circuit Range
221.25-244.45
Delivery %
0 %
Value
11.26 L
ASM/GSM
No
Market Lot
1
Samrat Pharmachem Resistance and Support
Pivot 240.05
Resistance
First Resistance
248.15
Second Resistance
254.6
Third Resistance
262.7
Support
First Support
233.6
Second Support
225.5
Third Support
219.05
Samrat Pharmachem Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 244 | 232 | -4.01% | 247.95 | 232 |
| Wed Sep 30 2026 | 239.89 | 241.69 | 2.44% | 246.5 | 231.94 |
| Tue Sep 29 2026 | 233 | 235.94 | 1.33% | 239.89 | 230 |
Samrat Pharmachem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
Samrat Pharmachem News
Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Board Meeting Intimation For Un-Audited Financial Results For The Quarter Ended September 30, 2026
Samrat Pharmachem board will convene on November 14, 2026, to consider and approve its Q2 FY27 financial results. This meeting will review the unaudited financial performance for the quarter ending September 30, 2026.
Sep 26 2026 15:12:12
Samrat Pharmachem Management
| Name | Position |
|---|---|
| Nishant Kankaria | Company Secretary & Compliance Officer |
| Lalit Mehta | Chairman & Managing Director |
Samrat Pharmachem Similar Stocks
Brooks Laboratories Ltd.
55.85
0.35 (0.63%)
Syschem (India) Ltd.
34.96
-0.51 (1.44%)
Auro Laboratories Ltd.
243.80
-1.20 (0.49%)
Smruthi Organics Ltd.
154.60
-3.90 (2.46%)
Aspira Pathlab & Diagnostics Ltd.
131.25
-6.53 (4.74%)
Lotus Eye Hospital And Institute Ltd.
116.45
0.45 (0.39%)
Lasa Supergenerics Ltd.
5.67
0.00 (0.00%)
Samrat Pharmachem FAQs
The Buying Price of Samrat Pharmachem share is 232 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Samrat Pharmachem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Samrat Pharmachem, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Samrat Pharmachem shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Samrat Pharmachem shares is 0. Useful to assess the stock's value relative to its book value.
To assess Samrat Pharmachem’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Samrat Pharmachem is 71.94 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Samrat Pharmachem share price is 320.00 & 190.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Samrat Pharmachem belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SAMRATPH
